Clinical trial
Onlay Synthetic Bioabsorbable Mesh Herniorrhaphy Versus Herniorrhaphy Only in the Primary Treatment of Large Hiatal Hernia: a Multicenter, Randomized, Parallel-group, Evaluator Blinded, Phase III Clinical Trial
NCT05867225 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Onlay Synthetic Bioabsorbable Mesh Herniorrhaphy Versus Herniorrhaphy Only in the Primary Treatment of Large Hiatal Hernia: a Multicenter, Randomized, Parallel-group, Evaluator Blinded, Phase III Clinical Trial
- Lead sponsor
- University Hospital, Bordeaux
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 15, 2024
- Completion date
- January 18, 2028
- Enrollment
- 256 (estimated)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.
large hiatal hernia